Fig. 5From: Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control studyDeath risk curve of Barcelona Clinic Liver Cancer (BCLC) A/B hepatocellular carcinoma patients treated with transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) or TACE aloneBack to article page